In general, estrogen activity mediated via ERα is proliferative and anti-apoptotic and has therefore been implicated in many proliferative diseases, such as prostate cancer, breast cancer, and autoimmune disorders (23, 31, 34). This evidence concerns the gene ESR1 and breast carcinoma.